Perceptions of our market

George Hickey

Quotes

“Spread Bets on Steroids”

2

“Lucky Dip Investments”

First Meeting

3

What are Structured Products exactly?

4

HSBC 6 Year ≈ 3.8%

Issuer: HSBC Bank PlcStatus: Senior unsecuredRatings: Aa3 (M) / AA- (S) / AA- (F)Trade Date:Term: 6 YearsClearing: CRESTPrinciple: 100Coupon: 3.8%

HSBC US Supertracker

Issuer: HSBC Bank PlcStatus: Senior unsecuredRatings: Aa3 (M) / AA- (S) / AA- (F)Trade Date: Term: 6 YearsClearing: CRESTPrinciple: 100Return: Linked to S&P500 Index

Observation Index Level Payout16th August 2016 >100% 179% x S&P16th August 2016 <100% >60% 100%16th August 2016 <60% 1:1

IT’S A BOND WITH DIFFERENT RISK/REWARD PAYOFF

New Investors : Concerns

5

CostsComplexity

Liquidity

INSTITUTIONAL VS RETAIL

Previous Investors : Been Burnt

6

ELDeRS (Liquidity)

Private Banks (not consistent AA)

CREDIT SPREADS (M2M)

Where do they fit in portfolios

How do you allocate them?

Positioning

How much in a portfolio?

EoY Survey suggests: Over ⅔ of buyers have

between 3% - 10% within portfolios.

7

The Approach

8

New Investors Journey

Called and introduced CLS

Booked meeting and went to visit

Followed up to book ‘teach-in’ CPD session

Held CPD session in their offices

Explained Central Research Process

Highlighted Central Launch

Investment Made

Ongoing Support and Advice

Previous Investors Journey

Re-engaged via personal contact

Initial meeting

Concerns raised

Held ‘under the bonnet’ models session at CLS HQ

Provided detailed M2M analysis

Continued ongoing meetings and support

Reassurance provided

Investment Made?

How do we get to 3%-10% across portfolios?

What would be your approach?

Disclaimer

This is a marketing communication and has not been prepared in accordance with legal requirements designed to promote independence of investment research and

is not subject to any prohibition of dealing ahead of the dissemination of investment research.

The information in this document is derived from sources believed to be reliable but which have not been independently verified. Any prices included within this

communication are for indicative purposes only. Catley Lakeman Securities makes no guarantee of its accuracy and completeness and is not responsible for errors of

transmission of factual or analytical data, nor is it liable for damages arising out of any person’s reliance upon this information. All charts and graphs are from publicly

available sources or proprietary data. The opinions in this document constitute the present judgment of Catley Lakeman Securities, which is subject to change without

notice.

This document is neither an offer to sell, purchase or subscribe for any investment nor a solicitation of such an offer. This document is intended for the use of

institutional and professional customers and is not intended for the use of private customers. This document is not intended for distribution in the United States of

America or to US persons. This document is intended to be distributed in its entirety. No consideration has been given to the particular investment objectives, financial

situation or particular needs of any recipient.

Catley Lakeman Securities is regulated by the Financial Conduct Authority. Firm FSA Reference No. 484826. Catley Lakeman Securities is the trading name of

Catley Lakeman LLP. Registered Office: One Eleven Edmund Street, Birmingham. B3 2HJ. Registration Number: OC336585

DISCLAIMER

10